![Sarah McCabe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ms. Sarah McCabe is a Senior Vice President at Stern Investor Relations, Inc. and a Head-Investor Relations at Evommune, Inc.
Postes actifs de Sarah McCabe
| Sociétés | Poste | Début |
|---|---|---|
| EVOMMUNE, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Corporate Officer/Principal | 01/01/2004 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Finance |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
